ICY.F
Incyte Corporation
FrankfurtEUREQUITY
Healthcare
DELAYED
Last price
110.20
▼ 0.55 (0.50%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
107.90
Prev close
110.75
Day high
110.20
Day low
107.90
Volume
55
Market cap
$22.34B
P/E (TTM)
16.42
52W range
69.58 – 115.40
Day trading desk
Gap from prior close
-2.57%
Prior close 110.75
VWAP
110.20
0.00% from price
Relative volume
1.62×
Unusually busy
Session range
2.13%
107.90 – 110.20
Position in range
100%
Near session high
ATR (14D)
1.29
1.17% of price
Prior day high
110.75
PDH
Prior day low
109.85
PDL
Bid / ask spread
—
Quote not published
Session volume
55
Avg 34
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
+6.68%
+7.8%
1M
+8.20%
+4.8%
3M
+32.61%
+30.2%
6M
+29.07%
+17.2%
YTD
+31.32%
+19.3%
1Y
+52.72%
+32.5%
3Y
+86.27%
+11.2%
5Y
+82.57%
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on ICY.F open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
3.72M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Aug 19, 26 | CAGNONI PABLO J Officer |
SELL | 10.80K | $1.36M | Direct |
| Aug 12, 26 | CAGNONI PABLO J Officer |
SELL | 10.80K | $1.30M | Direct |
| Aug 5, 26 | CAGNONI PABLO J President |
SELL | 10.64K | $1.31M | Direct |
| Aug 5, 26 | MAYES PATRICK A Officer |
SELL | 2.21K | $273.65K | Direct |
| Aug 5, 26 | MAYES PATRICK A Officer |
CONVERSION | 2.21K | $234.98K | Direct |
| Aug 3, 26 | MAYES PATRICK A Officer |
SELL | 47.95K | $5.73M | Direct |
| Aug 3, 26 | MAYES PATRICK A Officer |
CONVERSION | 45.77K | $3.59M | Direct |
| Jul 31, 26 | CAGNONI PABLO J Officer |
SELL | 15.89K | $1.90M | Direct |
| Jul 16, 26 | STEIN STEVEN H. Officer |
SELL | 1.88K | $215.35K | Direct |
| Jul 16, 26 | ISSA MOHAMED KHAIRIE Officer |
SELL | 1.09K | $125.71K | Direct |
| Jul 16, 26 | CAGNONI PABLO J President |
STOCK | 13.40K | $0 | Direct |
| Jul 16, 26 | MEURY WILLIAM Chief Executive Officer |
STOCK | 26.81K | $0 | Direct |
| Jul 16, 26 | STEIN STEVEN H. Officer |
STOCK | 9.80K | $0 | Direct |
| Jul 16, 26 | TRAY THOMAS R Officer |
STOCK | 2.83K | $0 | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
BAKER BROS ADVISORS L.P. |
Beneficial Owner of more than 10% of a Class of Security | — | Stock Award(Grant) |
BAKER BROTHERS LIFE SCIENCES L P |
Director and Beneficial Owner of more than 10% of a Class of Security | — | Stock Award(Grant) |
CAGNONI PABLO J |
Officer | 183.20K | Sale |
HOPPENOT HERVE |
Director | 329.65K | Sale |
ISSA MOHAMED KHAIRIE |
Officer | 71.80K | Sale |
IYENGAR VIJAY K |
Officer | 40.54K | Sale |
MAYES PATRICK A |
Officer | 61.44K | Sale |
MEURY WILLIAM |
Chief Executive Officer | 183.13K | Stock Award(Grant) |
STAMOULIS CHRISTIANA |
Chief Financial Officer | 125.76K | Stock Award(Grant) |
SWAIN PAULA J |
Officer | 106.48K | Stock Award(Grant) |
Fundamentals
Market cap$22.34B
Enterprise value$17.95B
Revenue (TTM)$5.82B
Gross profit$3.24B
EBITDA$1.94B
Net income$1.61B
EPS (TTM)$6.71
Free cash flow$1.18B
Total cash$4.54B
Total debt$38.27M
Book value / share$27.04
Shares outstanding202.70M
Float170.75M
Short % of float—
Dividend yield—
Beta (5Y)0.77
Valuation & profitability ratios
Trailing P/E16.42
Forward P/E24.99
PEG ratio31.23
Price / sales—
Price / book4.07
EV / revenue3.09
EV / EBITDA9.24
Gross margin55.66%
Operating margin41.90%
Profit margin27.71%
Return on equity30.67%
Return on assets16.83%
Debt / equity0.60
Current ratio4.59
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $5.14B | $4.24B | $3.70B | $3.39B | +21.2% |
| Operating revenue | $5.14B | $4.24B | $3.70B | $3.39B | +21.2% |
| Cost of revenue | $372.10M | $312.10M | $254.99M | $207.00M | +19.2% |
| Gross profit | $4.77B | $3.93B | $3.44B | $3.19B | +21.4% |
| Research & development | $2.05B | $2.61B | $1.63B | $1.59B | -21.4% |
| Selling, general & admin | $1.38B | $1.22B | $1.16B | $1.00B | +12.6% |
| Total operating expense | $3.43B | $3.83B | $2.79B | $2.60B | -10.5% |
| Operating income | $1.34B | $101.29M | $655.36M | $591.63M | +1,225.6% |
| Net interest income | $103.17M | $126.43M | $155.86M | $37.78M | -18.4% |
| Pre-tax income | $1.66B | $316.63M | $834.22M | $529.12M | +425.7% |
| Tax provision | $377.80M | $284.01M | $236.62M | $188.46M | +33.0% |
| Net income | $1.29B | $32.62M | $597.60M | $340.66M | +3,845.0% |
| Net income to common | $1.29B | $32.62M | $597.60M | $340.66M | +3,845.0% |
| Basic EPS | 6.59 | 0.16 | 2.67 | 1.53 | +4,018.8% |
| Diluted EPS | 6.41 | 0.15 | 2.65 | 1.52 | +4,173.3% |
| EBIT | $1.67B | $318.91M | $836.77M | $531.78M | +422.7% |
| EBITDA | $1.76B | $408.16M | $919.43M | $599.64M | +331.2% |
| Basic shares | 195.20M | 207.11M | 223.63M | 222.00M | -5.7% |
| Diluted shares | 200.70M | 210.53M | 225.93M | 223.96M | -4.7% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $3.10B | $1.69B | $3.21B | $2.95B | +83.5% |
| Cash & short-term investments | $3.58B | $2.16B | $3.66B | $3.24B | +65.9% |
| Accounts receivable | $1.02B | $853.15M | $743.56M | $644.88M | +20.1% |
| Inventory | $101.06M | $58.87M | $62.97M | $41.99M | +71.7% |
| Total current assets | $5.02B | $3.24B | $4.65B | $4.09B | +55.1% |
| Property, plant & equipment | $758.40M | $794.21M | $777.05M | $765.61M | -4.5% |
| Goodwill & intangibles | $250.13M | $269.40M | $279.14M | $284.81M | -7.2% |
| Total assets | $6.96B | $5.44B | $6.78B | $5.84B | +27.8% |
| Total current liabilities | $1.52B | $1.64B | $1.24B | $1.16B | -7.7% |
| Total debt | $40.41M | $43.54M | $38.29M | $41.46M | -7.2% |
| Total liabilities | $1.79B | $2.00B | $1.59B | $1.47B | -10.3% |
| Retained earnings | $213.77M | -$1.07B | $160.38M | -$437.21M | +119.9% |
| Shareholder equity | $5.17B | $3.45B | $5.19B | $4.37B | +49.9% |
| Working capital | $3.51B | $1.60B | $3.41B | $2.94B | +119.7% |
| Net tangible assets | $4.92B | $3.18B | $4.91B | $4.09B | +54.7% |
| Shares issued | 198.46M | 193.43M | 224.29M | 222.75M | +2.6% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $1.29B | $32.62M | $597.60M | $340.66M | +3,845.0% |
| Depreciation & amortisation | $93.29M | $89.25M | $82.66M | $67.86M | +4.5% |
| Stock-based compensation | $249.35M | $266.06M | $215.89M | $188.42M | -6.3% |
| Change in working capital | -$527.16M | $138.24M | -$248.65M | $198.81M | -481.3% |
| Operating cash flow | $1.41B | $335.34M | $496.49M | $969.94M | +321.5% |
| Capital expenditure | -$83.87M | -$100.16M | -$47.49M | -$77.83M | +16.3% |
| Investing cash flow | -$102.61M | $157.52M | -$207.68M | -$78.54M | -165.1% |
| Share buybacks | $0 | -$2.00B | $0 | $0 | +100.0% |
| Financing cash flow | $101.04M | -$2.02B | -$20.03M | -$794.00K | +105.0% |
| Free cash flow | $1.33B | $235.17M | $449.00M | $892.11M | +465.4% |
| End cash position | $3.10B | $1.69B | $3.22B | $2.95B | +83.5% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Total revenue | $1.67B | $1.27B | $1.51B | $1.37B | $1.22B | — | +31.5% |
| Operating revenue | $1.67B | $1.27B | $1.51B | $1.37B | $1.22B | — | +31.5% |
| Cost of revenue | $105.00M | $104.50M | $121.10M | $99.00M | $78.80M | — | +0.5% |
| Gross profit | $1.57B | $1.17B | $1.39B | $1.27B | $1.14B | — | +34.3% |
| Research & development | $516.95M | $515.90M | $611.37M | $506.58M | $494.92M | — | +0.2% |
| Selling, general & admin | $351.70M | $328.10M | $390.40M | $329.10M | $331.00M | — | +7.2% |
| Total operating expense | $868.65M | $844.00M | $1.00B | $835.68M | $825.92M | — | +2.9% |
| Operating income | $700.39M | $324.17M | $383.96M | $431.30M | $310.81M | — | +116.1% |
| Net interest income | $37.54M | $33.12M | $30.17M | $26.19M | $24.54M | — | +13.3% |
| Pre-tax income | $751.51M | $343.60M | $389.94M | $482.31M | $558.01M | — | +118.7% |
| Tax provision | $165.91M | $40.27M | $90.66M | $58.14M | $153.01M | — | +312.0% |
| Net income | $585.61M | $303.33M | $299.28M | $424.17M | $405.00M | — | +93.1% |
| Net income to common | $585.61M | $303.33M | $299.28M | $424.17M | $405.00M | — | +93.1% |
| Basic EPS | 2.92 | 1.52 | 1.52 | — | 2.09 | 0.82 | +92.1% |
| Diluted EPS | 2.81 | 1.47 | 1.46 | — | 2.04 | 0.80 | +91.2% |
| EBIT | $752.10M | $344.17M | $390.52M | $482.90M | $558.61M | — | +118.5% |
| EBITDA | $778.57M | $367.97M | $414.50M | $506.92M | $581.52M | — | +111.6% |
| Basic shares | 200.38M | 199.34M | 197.44M | — | 194.00M | 193.71M | +0.5% |
| Diluted shares | 208.22M | 206.83M | 204.77M | — | 198.74M | 198.20M | +0.7% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $3.98B | $3.46B | $3.10B | $2.46B | $1.95B | +15.1% |
| Cash & short-term investments | $4.54B | $4.02B | $3.58B | $2.93B | $2.42B | +12.9% |
| Accounts receivable | $1.13B | $1.05B | $1.02B | $895.89M | $842.89M | +7.0% |
| Inventory | $112.54M | $115.62M | $101.06M | $83.45M | $83.42M | -2.7% |
| Total current assets | $6.03B | $5.48B | $5.02B | $4.28B | $3.64B | +9.9% |
| Property, plant & equipment | $735.03M | $746.84M | $758.40M | $826.79M | $827.54M | -1.6% |
| Goodwill & intangibles | $236.20M | $243.16M | $250.13M | $275.01M | $282.01M | -2.9% |
| Total assets | $7.87B | $7.34B | $6.96B | $6.33B | $5.82B | +7.3% |
| Total current liabilities | $1.31B | $1.49B | $1.52B | $1.34B | $1.28B | -11.9% |
| Total debt | $38.27M | $39.43M | $40.41M | $41.27M | $42.41M | -2.9% |
| Total liabilities | $1.53B | $1.72B | $1.79B | $1.68B | $1.65B | -11.0% |
| Retained earnings | $1.10B | $517.10M | $213.77M | -$85.51M | -$509.68M | +113.2% |
| Shareholder equity | $6.34B | $5.62B | $5.17B | $4.65B | $4.17B | +12.8% |
| Working capital | $4.71B | $3.99B | $3.51B | $2.94B | $2.37B | +18.0% |
| Net tangible assets | $6.11B | $5.38B | $4.92B | $4.38B | $3.89B | +13.5% |
| Shares issued | 200.98M | 199.95M | 198.46M | 196.13M | 194.12M | +0.5% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2024-12-31 | YoY |
|---|---|---|---|---|---|---|---|
| Net income | $585.61M | $303.33M | $299.28M | $424.17M | $405.00M | — | +93.1% |
| Depreciation & amortisation | $26.48M | $23.80M | $23.98M | $24.02M | $22.92M | — | +11.2% |
| Stock-based compensation | $67.26M | $64.13M | $62.16M | $61.60M | $64.61M | — | +4.9% |
| Change in working capital | -$281.61M | -$91.34M | $103.20M | -$60.42M | -$582.96M | — | -208.3% |
| Operating cash flow | $507.66M | $369.35M | $543.30M | $559.39M | $44.74M | — | +37.4% |
| Capital expenditure | -$12.41M | -$15.20M | -$21.88M | -$39.75M | -$19.07M | — | +18.3% |
| Investing cash flow | -$51.79M | -$88.20M | -$37.42M | -$47.42M | -$18.87M | — | +41.3% |
| Share buybacks | — | — | $0 | $0 | — | $0 | — |
| Financing cash flow | $65.46M | $84.82M | $137.74M | -$12.78M | -$11.25M | — | -22.8% |
| Free cash flow | $495.25M | $354.15M | $521.42M | $519.64M | $25.67M | — | +39.8% |
| End cash position | $3.98B | $3.46B | $3.10B | $2.46B | $1.96B | — | +15.1% |
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | — | — | $1.47B | +8.0% |
| Next quarter | — | — | $1.53B | +1.4% |
| Current year | — | — | $5.94B | +15.6% |
| Next year | — | — | $6.27B | +5.4% |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
ConsensusNONE
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders1.83%
Held by institutions103.83%
Institutions holding1.29K
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
106.14
+3.83% from price
SMA 20
105.97
+3.99% from price
SMA 50
100.98
+9.13% from price
SMA 100
92.22
+19.49% from price
SMA 200
89.03
+23.78% from price
EMA 12
106.69
+3.29% from price
EMA 26
104.64
+5.31% from price
EMA 50
100.97
+9.14% from price
RSI (14)
64.2
Neutral
MACD (12,26,9)
2.05
Hist 0.32
ATR (14)
1.29
1.17% of price
Realised vol 30D
42.4%
Annualised
Bollinger upper
112.68
20, 2σ
Bollinger lower
99.26
20, 2σ
50 / 200 cross
Golden
100.98 vs 89.03
Trend bias
Above 200
+23.78%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
-0.32
Less volatile than market
Correlation to SPY
-0.11
Largely independent
Realised vol 30D
42.4%
Annualised
Market vol 1Y
12.8%
SPY, annualised
Max drawdown 1Y
-18.6%
Peak to trough
Max drawdown 5Y
-42.5%
Peak to trough
ATR 14
1.29
1.17% of price
Beta (reported)
0.77
5Y monthly, from filing
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 20, 26 | Canaccord Genuity | INITIATED | — | Buy |
| Aug 20, 26 | HC Wainwright & Co. | MAINTAINED | Buy | Buy |
| Aug 17, 26 | Piper Sandler | MAINTAINED | Overweight | Overweight |
| Aug 4, 26 | Mizuho | MAINTAINED | Outperform | Outperform |
| Aug 3, 26 | Leerink Partners | MAINTAINED | Outperform | Outperform |
| Aug 3, 26 | HC Wainwright & Co. | MAINTAINED | Buy | Buy |
| Jul 29, 26 | RBC Capital | MAINTAINED | Sector Perform | Sector Perform |
| Jul 29, 26 | Guggenheim | MAINTAINED | Buy | Buy |
| Jul 29, 26 | BMO Capital | MAINTAINED | Market Perform | Market Perform |
| Jul 29, 26 | Barclays | MAINTAINED | Overweight | Overweight |
| Jul 29, 26 | HC Wainwright & Co. | MAINTAINED | Buy | Buy |
| Jul 23, 26 | JP Morgan | MAINTAINED | Neutral | Neutral |
Dividends & splits
Forward rate—
Forward yield—
5-year avg yield—
Payout ratio0.00%
Ex-dividend date—
Next pay date—
Last split2:1
Split dateNov 10, 1997
Headlines
Peako to launch UAV magnetic surveys across five Saudi projects
Mining Technology · 1m ago
Canada's Carney to Announce New Investments to Strengthen Trade Routes After US Talks Collapse
MT Newswires · 3m ago
Leidos Wins $301 Million Cyber Defense Contract
MT Newswires · 5m ago
Davidson Kempner Capital Management LP : Form 8.3 - easyJet plc
GlobeNewswire · 6m ago
Billionaire Stanley Druckenmiller Bought Amazon and Alphabet in Q2. But His Single Biggest Holding Is Neither of Them -- and It's Not Nvidia Either.
Motley Fool · 6m ago
United Vein & Vascular Centers Expands Tampa Bay Network With New South Tampa Vein Clinic
PR Newswire · 7m ago
Brake problems in GM EVs draw greater federal scrutiny
TechCrunch · 7m ago
BetterHelp Has the Demand: Can Teladoc Build the Capacity?
Zacks · 8m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.